These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 17439507)
21. A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitis. Marakhouski Y; Fixa B; Holomán J; Hulek P; Lukas M; Bátovský M; Rumyantsev VG; Grigoryeva G; Stolte M; Vieth M; Greinwald R; Aliment Pharmacol Ther; 2005 Jan; 21(2):133-40. PubMed ID: 15679762 [TBL] [Abstract][Full Text] [Related]
22. p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Meijers BK; De Preter V; Verbeke K; Vanrenterghem Y; Evenepoel P Nephrol Dial Transplant; 2010 Jan; 25(1):219-24. PubMed ID: 19692415 [TBL] [Abstract][Full Text] [Related]
23. Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study. Paoluzi OA; Iacopini F; Pica R; Crispino P; Marcheggiano A; Consolazio A; Rivera M; Paoluzi P Aliment Pharmacol Ther; 2005 May; 21(9):1111-9. PubMed ID: 15854173 [TBL] [Abstract][Full Text] [Related]
24. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder. Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729 [TBL] [Abstract][Full Text] [Related]
25. Inulin and oligofructose in the dietary fibre concept. Cherbut C Br J Nutr; 2002 May; 87 Suppl 2():S159-62. PubMed ID: 12088513 [TBL] [Abstract][Full Text] [Related]
26. Intestinal Permeability in Children with Celiac Disease after the Administration of Oligofructose-Enriched Inulin into a Gluten-Free Diet-Results of a Randomized, Placebo-Controlled, Pilot Trial. Drabińska N; Krupa-Kozak U; Jarocka-Cyrta E Nutrients; 2020 Jun; 12(6):. PubMed ID: 32531982 [TBL] [Abstract][Full Text] [Related]
27. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers. Joshi S; Lewis SJ; Creanor S; Ayling RM Ann Clin Biochem; 2010 May; 47(Pt 3):259-63. PubMed ID: 19740914 [TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of inulin and oligofructose supplementation in infant formula: results from a randomized clinical trial. Closa-Monasterolo R; Gispert-Llaurado M; Luque V; Ferre N; Rubio-Torrents C; Zaragoza-Jordana M; Escribano J Clin Nutr; 2013 Dec; 32(6):918-27. PubMed ID: 23498848 [TBL] [Abstract][Full Text] [Related]
29. Calcium and colorectal epithelial cell proliferation in ulcerative colitis. Bostick RM; Boldt M; Darif M; Wood JR; Overn P; Potter JD Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1021-7. PubMed ID: 9419397 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitis. Gibson PR; Fixa B; Pekárková B; Bátovský M; Radford-Smith G; Tibitanzl J; Gabalec L; Florin TH; Greinwald R Aliment Pharmacol Ther; 2006 Apr; 23(7):1017-26. PubMed ID: 16573804 [TBL] [Abstract][Full Text] [Related]
31. Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels. Valcheva R; Koleva P; Martínez I; Walter J; Gänzle MG; Dieleman LA Gut Microbes; 2019; 10(3):334-357. PubMed ID: 30395776 [TBL] [Abstract][Full Text] [Related]
32. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis. Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519 [TBL] [Abstract][Full Text] [Related]
33. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796 [TBL] [Abstract][Full Text] [Related]
34. Fecal calprotectin in first-degree relatives of patients with ulcerative colitis. Montalto M; Curigliano V; Santoro L; Armuzzi A; Cammarota G; Covino M; Mentella MC; Ancarani F; Manna R; Gasbarrini A; Gasbarrini G Am J Gastroenterol; 2007 Jan; 102(1):132-6. PubMed ID: 17100982 [TBL] [Abstract][Full Text] [Related]
35. Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response. Turner D; Leach ST; Mack D; Uusoue K; McLernon R; Hyams J; Leleiko N; Walters TD; Crandall W; Markowitz J; Otley AR; Griffiths AM; Day AS Gut; 2010 Sep; 59(9):1207-12. PubMed ID: 20801771 [TBL] [Abstract][Full Text] [Related]
36. A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans. Kolida S; Meyer D; Gibson GR Eur J Clin Nutr; 2007 Oct; 61(10):1189-95. PubMed ID: 17268410 [TBL] [Abstract][Full Text] [Related]
37. Inulin and oligofructose: effects on lipid metabolism from human studies. Williams CM; Jackson KG Br J Nutr; 2002 May; 87 Suppl 2():S261-4. PubMed ID: 12088527 [TBL] [Abstract][Full Text] [Related]
38. Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects. Delzenne NM; Daubioul C; Neyrinck A; Lasa M; Taper HS Br J Nutr; 2002 May; 87 Suppl 2():S255-9. PubMed ID: 12088526 [TBL] [Abstract][Full Text] [Related]
39. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Miehlke S; Madisch A; Bethke B; Morgner A; Kuhlisch E; Henker C; Vogel G; Andersen M; Meier E; Baretton G; Stolte M Gastroenterology; 2008 Nov; 135(5):1510-6. PubMed ID: 18926826 [TBL] [Abstract][Full Text] [Related]
40. Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm. Husebye E; Tøn H; Johne B Am J Gastroenterol; 2001 Sep; 96(9):2683-7. PubMed ID: 11569695 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]